Alantra, the global mid-market investment banking firm, has appointed Anthony Harrington as a partner and key member of its healthcare advisory team.
Anthony has over fifteen years of M&A experience in the healthcare sector having worked on more than 40 M&A transactions and a variety of strategic advisory projects for clients in the UK, US, Europe and Asia. He will be based in the company’s London office.
Prior to joining Alantra, Anthony held positions in the healthcare teams at Results International, Bear Sterns and Rothschild. He has advised high-profile pharma services business including Cherry Healthcare on its sale to Avenir Global, Prescient Healthcare Group on the investment from Baird Capital, Lucid Group on the investment from LDC, STEM on its £84m sale to UDG PLC and Hive on its £50m sale to St Ives PLC. He also sits on the awards judging panel for healthcare industry body, Communiqué.
Andy Currie, managing partner of Alantra’s UK advisory business, said: “Deep sector experience and senior-led transaction advice are key elements of the Alantra offering. This marries well with the needs of our healthcare clients and it is great to be able to welcome Anthony to the team. We are absolutely committed to attracting the highest quality talent and investing behind our people in our chosen markets as we grow the Alantra business both in the UK and globally.”
